← Leaderboards
Joanne L. Flynn
University Of Pittsburgh At Pittsburgh
$43,717,509
Attributed
$67,630,674
Total exposure
25
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.5M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$67,630,674 · 25
By mechanism
R01$54,506,281 · 17
T32$5,057,623 · 1
U01$2,949,071 · 1
P01$2,312,860 · 1
UH2$1,171,191 · 1
R56$787,116 · 1
Top collaborators
- Denise E Kirschner22 shared
- Jennifer Jean Linderman13 shared
- Philana Ling Lin13 shared
- Sabine Ehrt8 shared
- Dirk Schnappinger8 shared
- Sarah M Fortune6 shared
- Eric Joseph Rubin5 shared
- Carolyn J Anderson4 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Sharon Riddler$22,034,939
- Eric Joseph Rubin$20,208,402
- Philana Ling Lin$10,232,778
- Dario Aa Vignali$40,087,127
- William E Klunk$26,129,826
Others in their field
Top investigators on “Tuberculosis”
- Judith S. Currier · University Of California Los Angeles$301,722,065
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$297,204,160
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$267,912,117
- Lawrence Corey · Fred Hutchinson Cancer Center$255,939,398
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$200,192,298
- Sharon A Nachman · Johns Hopkins University$194,852,226
Research focus
TuberculosisMycobacterium TuberculosisInfectionGranulomaImmune ResponseNonhuman PrimateAnimal ModelCellsLungResponseCessation Of LifeVaccinesPathologyImmunePathogenTissuesCytokineComplexMacacaT-LymphocyteCollaborationsPreventImmunologyKillings
Grant awards (120)
Oral BCG: Optimizing mucosal vaccination against tuberculosis$1,162,224
R01 · FY2025 · AI
M. tuberculosis carbon metabolism during infection$817,108
R01 · FY2025 · AI
Enhancing cytotoxic lymphocytes in a TB vaccine strategy$728,788
R01 · FY2025 · AI · contact PI
Immunology of Infections Disease Renewal 2023$404,476
T32 · FY2025 · AI · contact PI
M. tuberculosis carbon metabolism during infection$939,332
R01 · FY2024 · AI
Enhancing cytotoxic lymphocytes in a TB vaccine strategy$762,587
R01 · FY2024 · AI · contact PI
Dissecting the pathogenesis of HIV-TB Immune reconstitution inflammatory syndrome$739,545
R01 · FY2024 · AI
Immunology of Infections Disease Renewal 2023$399,396
T32 · FY2024 · AI · contact PI
Development of a Self Inactivating, Highly Effective TB Vaccine$786,054
R01 · FY2023 · AI · contact PI
Enhancing cytotoxic lymphocytes in a TB vaccine strategy$773,531
R01 · FY2023 · AI · contact PI
Dissecting the pathogenesis of HIV-TB Immune reconstitution inflammatory syndrome$750,630
R01 · FY2023 · AI
M. tuberculosis carbon metabolism during infection$652,282
R01 · FY2023 · AI
Development of a Self Inactivating, Highly Effective TB Vaccine$787,367
R01 · FY2022 · AI · contact PI
Enhancing cytotoxic lymphocytes in a TB vaccine strategy$772,170
R01 · FY2022 · AI · contact PI
Dissecting the pathogenesis of HIV-TB Immune reconstitution inflammatory syndrome$763,732
R01 · FY2022 · AI
Development of a Self Inactivating, Highly Effective TB Vaccine$807,595
R01 · FY2021 · AI · contact PI
Dissecting the pathogenesis of HIV-TB Immune reconstitution inflammatory syndrome$765,082
R01 · FY2021 · AI
Development of a Self Inactivating, Highly Effective TB Vaccine$780,015
R01 · FY2020 · AI · contact PI
Efficacy of combination therapy in the Cynomolgus macaque model$776,152
P01 · FY2020 · AI · contact PI
Dissecting the pathogenesis of HIV-TB Immune reconstitution inflammatory syndrome$775,815
R01 · FY2020 · AI
Predicting protective T-cell responses in Tuberculosis using a systems biology approach$704,080
R01 · FY2020 · AI
Immunology of Infectious Disease$294,699
T32 · FY2020 · AI · contact PI
Efficacy of combination therapy in the Cynomolgus macaque model$799,772
P01 · FY2019 · AI · contact PI
The Consequences of Reinfection with M. tuberculosis$730,762
R01 · FY2019 · AI · contact PI
Development of a Self Inactivating, Highly Effective TB Vaccine$721,271
R01 · FY2019 · AI · contact PI
A Multi-scale systems pharmacology approach to TB therapy$717,296
U01 · FY2019 · HL
Predicting protective T-cell responses in Tuberculosis using a systems biology approach$711,246
R01 · FY2019 · AI
PET Probes Targeting Immune Cells for Imaging Tuberculosis$692,236
R01 · FY2019 · AI · contact PI
Immunology of Infectious Disease$317,701
T32 · FY2019 · AI · contact PI
Contribution of CD8 T cells in Controlling Tuberculosis$787,116
R56 · FY2018 · AI
The Consequences of Reinfection with M. tuberculosis$744,863
R01 · FY2018 · AI · contact PI
Predicting protective T-cell responses in Tuberculosis using a systems biology approach$727,947
R01 · FY2018 · AI
A Multi-scale systems pharmacology approach to TB therapy$717,122
U01 · FY2018 · HL
PET Probes Targeting Immune Cells for Imaging Tuberculosis$692,236
R01 · FY2018 · AI
Efficacy of combination therapy in the Cynomolgus macaque model$359,352
P01 · FY2018 · AI · contact PI
Immunology of Infectious Disease$287,189
T32 · FY2018 · AI · contact PI
An adjuvant that promotes TH1/TH17 and CD8 T cells in a tuberculosis vaccine$1,133,663
R01 · FY2017 · AI · contact PI
The Consequences of Reinfection with M. tuberculosis$736,682
R01 · FY2017 · AI · contact PI
Predicting protective T-cell responses in Tuberculosis using a systems biology approach$735,488
R01 · FY2017 · AI
A Multi-scale systems pharmacology approach to TB therapy$714,113
U01 · FY2017 · HL
PET Probes Targeting Immune Cells for Imaging Tuberculosis$707,272
R01 · FY2017 · AI
Immunology of Infectious Disease$274,277
T32 · FY2017 · AI · contact PI
Efficacy of combination therapy in the Cynomolgus macaque model$155,965
P01 · FY2017 · AI · contact PI
The Effects of M. tuberculosisInfection on Lung Microbiome in Macaques$77,968
R03 · FY2017 · AI · contact PI
Predicting immune responses that correlate with protection against tuberculosis$1,149,943
R01 · FY2016 · HL · contact PI
An adjuvant that promotes TH1/TH17 and CD8 T cells in a tuberculosis vaccine$1,124,887
R01 · FY2016 · AI · contact PI
A Multi-scale systems pharmacology approach to TB therapy$800,540
U01 · FY2016 · HL
Predicting protective T-cell responses in Tuberculosis using a systems biology approach$767,668
R01 · FY2016 · AI
The Consequences of Reinfection with M. tuberculosis$765,415
R01 · FY2016 · AI · contact PI
PET Probes Targeting Immune Cells for Imaging Tuberculosis$685,055
R01 · FY2016 · AI
Rational Design of Combination Regimens Targeting Both Host and Pathogen$571,191
UH2 · FY2016 · AI · contact PI
Immunology of Infectious Disease$306,883
T32 · FY2016 · AI · contact PI
Efficacy of combination therapy in the Cynomolgus macaque model$221,619
P01 · FY2016 · AI · contact PI
The Effects of M. tuberculosisInfection on Lung Microbiome in Macaques$91,365
R03 · FY2016 · AI · contact PI
Predicting immune responses that correlate with protection against tuberculosis$1,141,651
R01 · FY2015 · HL · contact PI
An adjuvant that promotes TH1/TH17 and CD8 T cells in a tuberculosis vaccine$1,027,582
R01 · FY2015 · AI · contact PI
PET Probes Targeting Immune Cells for Imaging Tuberculosis$740,094
R01 · FY2015 · AI
Rational Design of Combination Regimens Targeting Both Host and Pathogen$600,000
UH2 · FY2015 · AI · contact PI
The Consequences of Reinfection with M. tuberculosis$404,495
R01 · FY2015 · AI · contact PI
Immunology of Infectious Disease$302,766
T32 · FY2015 · AI · contact PI
Predicting immune responses that correlate with protection against tuberculosis$1,211,784
R01 · FY2014 · HL · contact PI
An adjuvant that promotes TH1/TH17 and CD8 T cells in a tuberculosis vaccine$878,466
R01 · FY2014 · AI · contact PI
A multi-scale model to predict outcomes of immunomodulation and drug therapy duri$573,969
R01 · FY2014 · EB
Immunology of Infectious Disease$302,766
T32 · FY2014 · AI · contact PI
Predicting immune responses that correlate with protection against tuberculosis$1,172,751
R01 · FY2013 · HL · contact PI
An adjuvant that promotes TH1/TH17 and CD8 T cells in a tuberculosis vaccine$951,064
R01 · FY2013 · AI · contact PI
Defining how the spectrum of latency affects reactivation of TB$614,716
R01 · FY2013 · HL · contact PI
A multi-scale model to predict outcomes of immunomodulation and drug therapy duri$559,666
R01 · FY2013 · EB
CD4 T Cells in Tuberculosis$458,364
R01 · FY2013 · AI · contact PI
Immunology of Infectious Disease$293,319
T32 · FY2013 · AI · contact PI
Predicting immune responses that correlate with protection against tuberculosis$1,252,487
R01 · FY2012 · HL · contact PI
Defining how the spectrum of latency affects reactivation of TB$646,562
R01 · FY2012 · HL · contact PI
A multi-scale model to predict outcomes of immunomodulation and drug therapy duri$595,013
R01 · FY2012 · EB
CD4 T Cells in Tuberculosis$487,620
R01 · FY2012 · AI · contact PI
Function of CD8 T Cells in Tuberculosis$321,452
R01 · FY2012 · AI · contact PI
Immunology of Infectious Disease$222,916
T32 · FY2012 · AI · contact PI
Defining how the spectrum of latency affects reactivation of TB$654,521
R01 · FY2011 · HL · contact PI
A multi-scale model to predict outcomes of immunomodulation and drug therapy duri$610,696
R01 · FY2011 · EB
CD4 T Cells in Tuberculosis$492,299
R01 · FY2011 · AI · contact PI
Function of CD8 T Cells in Tuberculosis$321,820
R01 · FY2011 · AI · contact PI
Immunology of Infectious Disease$252,616
T32 · FY2011 · AI · contact PI
Defining how the spectrum of latency affects reactivation of TB$675,044
R01 · FY2010 · HL · contact PI
CD4 T Cells in Tuberculosis$490,643
R01 · FY2010 · AI · contact PI
Function of CD8 T Cells in Tuberculosis$325,432
R01 · FY2010 · AI · contact PI
A Multi-scale and Multi-system Approach to Understand Granuloma Formation in TB$223,972
R33 · FY2010 · HL · contact PI
CD4 T Cells in Tuberculosis$500,566
R01 · FY2009 · AI · contact PI
Function of CD8 T Cells in Tuberculosis$329,073
R01 · FY2009 · AI · contact PI
Immunology of Infectious Disease$300,371
T32 · FY2009 · AI · contact PI
A Multi-scale and Multi-system Approach to Understand Granuloma Formation in TB$224,067
R33 · FY2009 · HL · contact PI
Function of CD8 T Cells in Tuberculosis$324,298
R01 · FY2008 · AI · contact PI
Immunology of Infectious Disease$298,583
T32 · FY2008 · AI · contact PI
A Multi-scale and Multi-system Approach to Understand Granuloma Formation in TB$224,160
R33 · FY2008 · HL · contact PI
Latent and Reactivation Tuberculosis$652,651
R01 · FY2007 · HL · contact PI
Immunology of Infectious Disease$298,180
T32 · FY2007 · AI · contact PI
Latent and Reactivation Tuberculosis$636,326
R01 · FY2006 · HL · contact PI
CD4 T Cells in Tuberculosis$463,263
R01 · FY2006 · AI · contact PI
Immunology of Infectious Disease$298,583
T32 · FY2006 · AI · contact PI
Function of CD8 T Cells in Tuberculosis$233,565
R01 · FY2006 · AI · contact PI
Latent and Reactivation Tuberculosis$635,416
R01 · FY2005 · HL
CD4 T Cells in Tuberculosis$460,689
R01 · FY2005 · AI
Function of CD8 T Cells in Tuberculosis$239,717
R01 · FY2005 · AI
Immunology of Infectious Disease$202,902
T32 · FY2005 · AI
Latent and Reactivation Tuberculosis$670,886
R01 · FY2004 · HL
CD4 T Cells in Tuberculosis$478,541
R01 · FY2004 · AI
Function of CD8 T Cells in Tuberculosis$240,234
R01 · FY2004 · AI
A NON-HUMAN PRIMATE MODEL OF TUBERCULOSIS AND AIDS$58,805
R01 · FY2004 · AI
Pathogen-Host Standoff: Persistent and Latent Infection$5,000
R13 · FY2004 · AI
Latent and Reactivation Tuberculosis$672,911
R01 · FY2003 · HL
A NON-HUMAN PRIMATE MODEL OF TUBERCULOSIS AND AIDS$572,261
R01 · FY2003 · AI
CD4 T Cells in Tuberculosis$461,721
R01 · FY2003 · AI
Function of CD8 T Cells in Tuberculosis$320,754
R01 · FY2003 · AI
A NON-HUMAN PRIMATE MODEL OF TUBERCULOSIS AND AIDS$538,200
R01 · FY2002 · AI
CD4 T Cells in Tuberculosis$467,797
R01 · FY2002 · AI
Function of CD8 T Cells in Tuberculosis$242,530
R01 · FY2002 · AI
A NON-HUMAN PRIMATE MODEL OF TUBERCULOSIS AND AIDS$573,820
R01 · FY2001 · AI
FUNCTION OF CD8T CELLS IN TUBERCULOSIS$148,163
R01 · FY2001 · AI
FUNCTION OF CD8T CELLS IN TUBERCULOSIS$15,000
R01 · FY2001 · AI
A NON-HUMAN PRIMATE MODEL OF TUBERCULOSIS AND AIDS$574,782
R01 · FY2000 · AI
HOST RESPONSE EFFECT ON MYCOBACTERIAL GENE EXPRESSION$147,251
R01 · FY2000 · AI
FUNCTION OF CD8T CELLS IN TUBERCULOSIS$144,299
R01 · FY2000 · AI